Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.
Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.
Lyell免疫製藥股價下跌，因公司發佈LYL797第一期臨床數據。
Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.
Lyell免疫製藥股價下跌，因公司發佈LYL797第一期臨床數據。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。